
Partner
Miclean Gleason LLP
Columns
Title | Category | Published |
---|---|---|
Another win for Sandoz; another nail in the coffin of the doctrine of equivalents | Civil Litigation, Intellectual Property | May 14, 2019 |
The biosimilar patent dance: When in doubt, list it | U.S. Supreme Court, Civil Litigation, Intellectual Property, Health Care & Hospital Law, Corporate, Contracts | Aug. 16, 2017 |
Verdicts & Settlements
Case Name | Topic | Role | Published |
---|---|---|---|
Allergan Inc., Duke University v. Apotex Inc., Sandoz Inc., Hi-Tech Pharmacal Co. Inc. | Intellectual Property | Plaintiff | May 4, 2013 |
Baxter Healthcare Corp., Deka Products LP, Baxter International Inc., Baxter Heathcare SA v. Fresenius Medical Care Holdings Inc. d.b.a. Fresenius Medical Care North America, Fresenius USA Inc. | Intellectual Property | Defendant | Sep. 11, 2010 |
Title | Category | Published |
---|---|---|
Another win for Sandoz; another nail in the coffin of the doctrine of equivalents | Civil Litigation, Intellectual Property | May 14, 2019 |
The biosimilar patent dance: When in doubt, list it | U.S. Supreme Court, Civil Litigation, Intellectual Property, Health Care & Hospital Law, Corporate, Contracts | Aug. 16, 2017 |
Case Name | Topic | Role | Published |
---|---|---|---|
Allergan Inc., Duke University v. Apotex Inc., Sandoz Inc., Hi-Tech Pharmacal Co. Inc. | Intellectual Property | Plaintiff | May 4, 2013 |
Baxter Healthcare Corp., Deka Products LP, Baxter International Inc., Baxter Heathcare SA v. Fresenius Medical Care Holdings Inc. d.b.a. Fresenius Medical Care North America, Fresenius USA Inc. | Intellectual Property | Defendant | Sep. 11, 2010 |